Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:907-912
doi: 10.1161/hy1001.091783
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bello, E.
Right arrow Articles by Casado, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bello, E.
Right arrow Articles by Casado, S.
Related Collections
Right arrow Lipids
Right arrow Remodeling
Right arrow Hypertrophy
Right arrow Clinical Studies
Right arrow Other diagnostic testing
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2001;38:907.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Impairment of Renal Vasodilation With L-Arginine Is Related to More Severe Disease in Untreated Hypertensive Patients

Elena Bello; Carlos Caramelo; Nieves Martell; José María Alcázar; Javier González; María Dolores López; Luis Miguel Ruilope; Francisco Román González; Adela María Rovira; Rosa Gazapo; María José Soldevilla; Santos Casado

From the Instituto de Investigaciones Médicas, Fundación Jiménez Díaz (E.B., C.C., J.G., M.D.L., F.R.G., R.M.G., M.J.S., S.C.), Hypertension Units, Hospital Clínico de San Carlos (N.M.), and Hospital Doce de Octubre (J.M.A., L.M.R.), Universidad Autónoma and Universidad Complutense; and Instituto Reina Sofía de Investigación Nefrológica (C.C., F.R.G., S.C.), Madrid, Spain.

Correspondence to Carlos Caramelo, MD, Laboratorio de Nefrología-Hipertensión, Fundación Jiménez Díaz, Universidad Autónoma, Av Reyes Católicos 2, 28040 Madrid, Spain. E-mail ccaramelo{at}fjd.es

Abstract— Data remain insufficient to place the decreased response to L-arginine in hypertensive patients within a consistent pathophysiological sequence. The aim of the present study in patients with essential hypertension was to assess the relationships between the response to L-arginine and a set of relevant clinical and laboratory parameters. In this prospective, interventional study, we administered L-arginine to untreated hypertensive individuals and healthy control subjects and measured the clearance of inulin and of para-aminohippurate and a set of biochemical and clinical variables. L-Arginine infusion revealed major differences between control subjects and 1 subgroup (group B) of hypertensive individuals. Group B hypertensives (n=18) had no increase in inulin clearance and no decrease in renal vascular resistance with L-arginine; however, in another subset of hypertensive patients (group A, n=27), the insulin clearance increased and renal vascular resistance decreased similar to the control group (group C, n=11). The ambulatory blood pressure monitoring in group B showed both an increased mean diastolic pressure and a "nondipper" pattern in the nocturnal regulation of arterial pressure. These findings in group B were accompanied by significant alterations in optic fundus and left ventricle hypertrophy and increased microalbuminuria (all, P<0.05). Furthermore, group B individuals had significantly lower values of HDL cholesterol and a higher baseline atherogenic index, plasma insulin level, and glucose/insulin index. We disclose a previously undescribed relationship between end organ repercussion and decreased renal hemodynamic response to L-arginine. Our results may help to understand the mechanisms that lead to target organ damage in hypertension.


Key Words: L-arginine • hypertension, essential • endothelium • blood pressure monitoring, ambulatory




This article has been cited by other articles:


Home page
CJASNHome page
V. E. Torres, B. F. King, A. B. Chapman, M. E. Brummer, K. T. Bae, J. F. Glockner, K. Arya, D. Risk, J. P. Felmlee, J. J. Grantham, et al.
Magnetic Resonance Measurements of Renal Blood Flow and Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 112 - 120.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. De Cobelli, P. Fiorina, G. Perseghin, M. Magnone, M. Venturini, G. Zerbini, A. Zanello, G. Mazzolari, L. Monti, V. Di Carlo, et al.
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Preserved in Uremic Type 1 Diabetic Patients After Kidney and Pancreas but not After Kidney-Alone Transplantation
Diabetes Care, April 1, 2004; 27(4): 947 - 954.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. A. Fischer, G. N. Dominguez, L. A. Cuniberti, V. Martinez, J. P. Werba, A. J. Ramirez, and L. D. Masnatta
Hyperhomocysteinemia Induces Renal Hemodynamic Dysfunction: Is Nitric Oxide Involved?
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 653 - 660.
[Abstract] [Full Text] [PDF]